Abstracts Archive - Page 569 of 2607 - ACR Meeting Abstracts

Abstract Number: 1288 • ACR Convergence 2022
How Often Do We Provide Relevant and Patient Centric Discharge Instructions in Rheumatology? A Single Academic Center Clinic Experience
Dijo Joseph¹, Asha Asthana², Sobia Hassan³ and Meenakshi Jolly³, ¹Rush University Medical Center, Chicago, IL, ²Rush University Medical Center Department of Internal Medicine, Chicago, IL, ³Rush University, Chicago, IL
Background/Purpose: Post-visit discharge instructions (DCI) are an important supplement to the patient visit that serves to reinforce a patient's understanding of their diagnosis, medications and…
Abstract Number: 1282 • ACR Convergence 2022
Practice Patterns for Pneumocystis Jiroveci Pneumonia (PJP) Prophylaxis Among Nephrologists and Rheumatologists – an International Survey Study
Swati Arora¹, Brad Rovin² and Tanmayee Bichile³, ¹Allegheny Health Network, Pittsburgh, ²The Ohio State University, Columbus, OH, ³Allegheny Health Network, Gibsonia, PA
Background/Purpose: Patients with autoimmune disorders such as systemic lupus erythematosus (SLE), lupus nephritis (LN) and granulomatosis with polyangiitis (GPA) frequently require treatment with immunosuppressive drugs.…
Abstract Number: 1294 • ACR Convergence 2022
Translation and Cross-cultural Adaptation of the CORS into Spanish
Victoria Navarro-Compán¹, Diego Benavent², Andrea Jochems³, Dora Pascual-Salcedo³, Gijs Jochems⁴, Sofia Ramiro⁵, Wim van Lankveld⁶ and Chamaida Plasencia-Rodriguez⁷, ¹Department of Rheumatology, La Paz University Hospital, IdiPaz, Madrid, Spain, ²La Paz University Hospital, Madrid, Spain, ³Immuno-Rheumatology Group, Hospital Universitario La Paz, Madrid, Spain, ⁴Promega Biotech Ibérica, Madrid, Spain, ⁵Leiden University Medical Center, Leiden, Netherlands, ⁶NA, Amsterdam, Netherlands, ⁷Rheumatology Department, La Paz University Hospital, Madrid, Spain
Background/Purpose: Rheumatic diseases substantially affect the lives of patients, with complex associations between disease severity and self-perceived health status. In this regard, the Coping with…
Abstract Number: 1295 • ACR Convergence 2022
Targeting Barriers That Prevent Contraception Counseling in an Academic Rheumatology Practice
Tara Skorupa¹, Kristin Sturm², Aaron Lazorwitz², Guiset Carvajal Bedoya³, Ju Young Kwag², JoAnn Zell² and Kristen Demoruelle², ¹University of Colorado, Aurora, CO, ²University of Colorado Anschutz Medical Campus, Aurora, CO, ³Billings Clinic, Billings, MT
Background/Purpose: Systemic autoimmune diseases disproportionately affect females of childbearing potential. Many of the medications used to treat systemic autoimmune diseases have suspected or confirmed teratogenic…
Abstract Number: 1285 • ACR Convergence 2022
Joint Injection Workflow in Rheumatology – an Opportunity to Improve Efficiency and Physician Satisfaction
Melissa Band¹, Eric Newman², Andrea Berger¹, Kirsten Koons³, Madhuri Duggirala¹, Rajesh Kuppuraju⁴, Peter Daniel Nicholas III⁵, David Bulbin⁶, David Pugliese⁷ and Jonida Cote⁸, ¹Geisinger Medical Center, Danville, PA, ²Geisinger, Danville, PA, ³Geisinger Medical Center, Lewisburg, PA, ⁴Geisinger Medical Center, General Rheumatology Fellowship, Danville, PA, ⁵Geisinger Medical Center, Leesport, PA, ⁶Geisinger Health System, Danville, PA, ⁷Geisinger Health System, Wilkes-Barre, PA, ⁸Geisinger Medical Center, Orefield, PA
Background/Purpose: Physicians strive to provide patient-centered, timely care, often with perceived inadequate blocked time on the schedule. We aim to understand the joint injection workflow,…
Abstract Number: 1293 • ACR Convergence 2022
Is Virtual Care Here to Stay? : Rheumatology Patients’ Satisfaction in Early vs Late Pandemic
Ummugulsum Gazel¹, Tommy Han², Seyyid Bilal Acikgoz³, Tara Swami¹, Hart goldhar⁴, Urusa Shah³, Rokshana Chowdhury³, Nataliya Milman³, Nancy Maltez¹, Catherine Ivory¹, Susan Humphrey-Murto³ and Sibel Aydin¹, ¹University of Ottawa, Rheumatology, Ottawa, Canada, Ottawa, ON, Canada, ²University of Ottawa, Medical School, Ottawa, Canada, Ottawa, ON, Canada, ³University of Ottawa, Rheumatology, Ottawa, Canada, Ottawa, Canada, ⁴William Osler Health Centre Etobicoke General Site, Rheumatology, Toronto, ON, Canada
Background/Purpose: The COVID-19 pandemic has dramatically changed the delivery of healthcare, with virtual care becoming the new standard. In the early stages of the pandemic,…
Abstract Number: 1306 • ACR Convergence 2022
Improving Osteoporosis Screening in Individuals of Color
Megan Brochu¹, Kristofer Marcus¹, Sarah Latorre¹, Francis Wanjau¹, Arvin Garg², Eric Alper², Rulan Lyu¹, Tracey Wilkie¹ and Jonathan Cheah³, ¹UMass Memorial Health, Worcester, MA, ²UMass Memorial Health, UMass Chan Medical School, Worcester, MA, ³UMass Chan Medical School, Worcester, MA
Background/Purpose: Osteoporosis, including the clinical event of fragility fracture is an ever-increasing public health burden. Effective screening techniques and well as therapies to reduce future…
Abstract Number: 1300 • ACR Convergence 2022
Impact of Demographics and Health Literacy on Transition Readiness for Adolescents with Rheumatic Disease
Maryem Al Manaa¹, Chan-hee Jo², Una Makris³, Nicole Bitencourt⁴, Tracey Wright⁵ and Lorien Nassi⁶, ¹UT Southwestern, Dallas, TX, ²Scottish Rite Hospital for Children, Dallas, TX, ³UT Southwestern Medical Center and Dallas VA, Dallas, TX, ⁴Loma Linda University Health, San Bernardino, CA, ⁵UT Southwestern, Plano, TX, ⁶University of Texas Southwestern, Dallas, TX
Background/Purpose: The transition to adult care for adolescents with rheumatic disease is a vulnerable period for many and can be associated with adverse outcomes. Adolescents…
Abstract Number: 1302 • ACR Convergence 2022
Assessment of the Transition of Care from Pediatric to Adult Rheumatology in a Tertiary Center
Serdal Ugurlu¹, Ali Yagiz Ayla¹, Helin Idil Besiroglu², Feyza Nur Azman¹, Bugra Egeli³, Hatice Eren¹, Ibrahim Durucan², Arif Alkan², Sila Ozturk¹, Sercan Ergun¹, Amra Adrovic Yildiz⁴, Kenan Barut⁵, Fatih Haslak¹, Sezgin Sahin¹, Mehmet YILDIZ¹, Huri Ozdogan⁶ and Ozgur Kasapcopur⁷, ¹Istanbul University-Cerrahpaşa, Istanbul, Turkey, ²Istanbul University-Cerrahpaşa Medical Faculty, Istanbul, Turkey, ³Children's Hospital of Los Angeles, Los Angeles, CA, ⁴School of Medicine, KOC University, Istanbul, Turkey, ⁵Istanbul University-Cerrahpasa, Istanbul, Turkey, ⁶Istanbul University-Cerrahpaşa Medical Faculty Department of Internal Medicine Division of Rheumatology, Istanbul, Turkey, ⁷Istanbul University-Cerrahpaşa, Cerrahpaşa Medical School, Istanbul, Turkey
Background/Purpose: Taking the responsibility for their own health should be an important goal for the patients in the health care transition process. The Transition Readiness…
Abstract Number: 1298 • ACR Convergence 2022
Pediatric Rheumatology Care and Outcomes Improvement Network Demonstrates Outcome Improvement for Children with Juvenile Idiopathic Arthritis
Catherine Bingham¹, Julia Harris², Sheetal Vora³, Mileka Gilbert⁴, Cagri Yildirim-Toruner⁵, Kerry Ferraro⁶, Tingting Qiu⁷, Jon Burnham⁸, Michelle Batthish⁹, Beth Gottlieb¹⁰, Daniel Lovell⁷, Ronald Laxer¹¹, Tzielan Lee¹², Danielle Bullock¹³, Charles H Spencer¹⁴, Jennifer Weiss¹⁵, Melissa Hazen¹⁶, Edward Oberle¹⁷, Melissa Mannion¹⁸, Nancy Pan¹⁹, Michael Shishov²⁰, Danielle Fair²¹, Mary Toth²², Kendra Wiegand⁷ and Esi Morgan²³, ¹Penn State Children's Hospital, Hershey, PA, ²Children's Mercy Kansas City, Overland Park, KS, ³Atrium Health Levine Children's, Charlotte, NC, ⁴Medical University of South Carolina, Charleston, SC, ⁵Texas Children's Hospital/ Baylor College of Medicine, Houston, TX, ⁶Pediatric Rheumatology Care and Outcomes Improvement Network, Philadelphia, ⁷Cincinnati Children's Hospital Medical Center, Cincinnati, OH, ⁸Children's Hospital of Philadelphia, Philadelphia, PA, ⁹McMaster University, Hamilton, ON, Canada, ¹⁰Cohen Children's Medical Center, Lake Success, NY, ¹¹Division of Rheumatology, The Hospital for Sick Children; Child Health Evaluative Services, SickKids Research Institute; Department of Paediatrics, University of Toronto, Toronto, ON, Canada, ¹²Stanford University School of Medicine, Palo Alto, CA, ¹³University of Minnesota, Minneapolis, MN, ¹⁴Division of Rheumatology, Nationwide Children’s Hospital and Department of Pediatrics, The Ohio State University, Columbus, MS, ¹⁵Hackensack University Medical Center, Hackensack, NJ, ¹⁶Boston Children's Hospital, Boston, MA, ¹⁷Division of Rheumatology, Nationwide Children's Hospital and Department of Pediatrics, The Ohio State University, Columbus, OH, ¹⁸University of Alabama at Birmingham, Birmingham, AL, ¹⁹Hospital for Special Surgery, New York, NY, ²⁰Phoenix Children's Hospital, Phoenix, AZ, ²¹Medical College of Wisconsin/Children's Wisconsin, Wauwatosa, WI, ²²Nemours Foundation, Orlando, FL, ²³Seattle Children's Hospital, Seattle, WA
Background/Purpose: Pediatric Rheumatology Care and Outcomes Improvement Network (PR-COIN) is a Learning Health Network designed to improve outcomes of care for children with juvenile idiopathic…
Abstract Number: 1309 • ACR Convergence 2022
Evaluation of Preference and Efficacy in the Treatment of Glucocorticoid-induced Osteoporosis in Patients with Autoimmune Diseases Receiving Zoledronic Acid
Ji-Won Kim¹, Ju-Yang Jung¹, Hyoun-Ah Kim¹ and Chang-Hee Suh², ¹Ajou University School of Medicine, Suwon, Republic of Korea, ²Ajou University Hospital, Suwon, Republic of Korea
Background/Purpose: The most commonly used drugs for glucocorticoid-induced osteoporosis (GIOP) is bisphosphonates, which include oral alendronate and risedronate, and intravenous zoledronic acid. Among them, zoledronic…
Abstract Number: 1308 • ACR Convergence 2022
Prevalence and Therapeutic Practices of Osteoporosis in Sarcoidosis in the United States: A Nationwide Registry Study
Diala Alawneh¹, Moustafa Younis², Romesa Hassan¹, Bashar Alzghoul², Shiva Arami¹, Tricha Shivas³, Mary McGowan³, Khaldoon Alawneh⁴, Christian Ascoli¹ and Nadera Sweiss¹, ¹University of Illinois at Chicago, Chicago, IL, ²University of Florida, Gainesville, FL, ³Foundation for Sarcoidosis Research, Chicago, IL, ⁴Jordan University of Science and Technology, Irbid, Jordan
Background/Purpose: Patients with sarcoidosis are at an increased risk of developing osteoporosis due to the active inflammatory state and chronic corticosteroid use. Proper dosing of…
Abstract Number: 1310 • ACR Convergence 2022
Is the Trabecular Bone Score (TBS) a Useful Tool in Patients with Diffuse Idiopathic Skeletal Hyperostosis (DISH)?
Bjoern Buehring¹, David Kiefer², Celina Mueller², Roshnak Parvaee², Marianti Ifanti², Ioana Andreica³, Timm Westhoff⁴, Rainer Wirth⁴, Xenofon Baraliakos⁵, Nina Babel⁴ and Juergen Braun², ¹Bergisches Rheuma-Zentrum, Wuppertal, Germany, ²Rheumazentrum Ruhrgebiet, Herne, Germany, ³Rheumazentrum Ruhrgebiet, Ruhr-Universität-Bochum, Herne, Germany, ⁴Marienhospital Herne, Ruhr-University Bochum, Herne, Germany, ⁵Rheumazentrum Ruhrgebiet Herne, Herne, Germany
Background/Purpose: Patients with rheumatic and musculoskeletal diseases (RMD) have an increased fracture risk (FxR). Diffuse idiopathic skeletal hyperostosis (DISH) is a non-inflammatory disease characterized by…
Abstract Number: 1252 • ACR Convergence 2022
Interrater Agreement of Hand Ultrasounds in Inflammatory Arthritis
Annie H Yang¹, Norman Madsen², Bethany Marston¹, Brian H. Nathanson³, Darren Tabechian⁴ and Allen Anandarajah⁵, ¹University of Rochester, Rochester, NY, ²University of Rochester, NY, Rochester, NY, ³OptiStatim, LLC, Longmeadow, MA, ⁴URMC, Rochester, NY, ⁵University of Rochester, Rochester
Background/Purpose: Musculoskeletal ultrasound (US) is an imaging modality that is more sensitive in identifying synovitis due to inflammatory arthritis than clinical examination. Little is known…
Abstract Number: 1201 • ACR Convergence 2022
Autoimmune Serologies, Cell-Bound Complement Activation Products, and Autoimmune Rheumatic Disease Symptoms After COVID-19 Infection
Emily G Oakes¹, Jack Ellrodt¹, Roberta Alexander², John Conklin², May Choi³, Hongshu Guan¹, Sara Tedeschi¹, Jeffrey Sparks⁴, Siobhan Case⁵, Tiffany Hsu¹, Daniel Solomon¹, Anna Jonsson¹ and Karen Costenbader¹, ¹Brigham and Women's Hospital, Boston, MA, ²Exagen, Inc., Vista, CA, ³Brigham and Women's Hospital | University of Calgary, Calgary, AB, Canada, ⁴Brigham and Women's Hospital and Harvard Medical School, Boston, MA, ⁵Brigham and Women's Hospital, Boston Children's Hospital, Boston, MA
Background/Purpose: Onset of autoimmune connective tissue disease (CTD) after COVID-19 infection has been reported and complement activation has been implicated. We examined common autoimmune rheumatic…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].